Reuters logo
5 months ago
BRIEF-Cyxone: independent laboratory confirms T20K's ability to prevent and brake multiple sclerosis in animal model
March 10, 2017 / 12:23 PM / 5 months ago

BRIEF-Cyxone: independent laboratory confirms T20K's ability to prevent and brake multiple sclerosis in animal model

1 Min Read

March 10 (Reuters) - Cyxone AB:

* Says independent laboratory at Monash University in Australia has verified Cyxones development substance T20K's ability to both prevent and brake multiple sclerosis in animal model

Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below